CBER Director Peter Marks (Jim Lo Scalzo/Pool via AP Images)
Next-gen Covid vaccines: No more quick variant updates and RCTs may be required, CBER leader writes
Gone are the days of Covid-19 vaccine developers promising to quickly shift their mRNA vaccines to target the next variant every three to four months.
Now, CBER Director Peter Marks is calling on the Modernas and BioNTech/Pfizers of the world to really start considering to develop a “distinctly improved generation of SARS-CoV-2 vaccines offering longer protection with greater scope.”
Writing in a JAMA viewpoint yesterday, Marks and two coauthors from Brown University’s medical school made clear that:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
